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S U M M A R Y
Objectives: The purpose of this study was to measure the prevalence of Chlamydia trachomatis (CT) and
Neisseria gonorrhoeae (GC) and the rates and factors associated with their over-treatment (OT) and
under-treatment (UT).
Methods: A retrospective chart review was performed of patients aged 13–24 years who were screened
for GC/CT in the emergency department (ED) of a public hospital. Descriptive statistics were obtained for
all variables, and multivariate log binomial regression was performed to ascertain the factors associated
with OT and UT.
Results: Seven hundred and ninety-seven adolescents and young adults were screened for GC/CT. The
overall sexually transmitted infection (STI) positivity rate was 21.6%; 136 (21.6%) subjects were over-
treated and 74 (43.4%) subjects were under-treated. Patients presenting with STI exposure or genito-
urinary symptoms were more likely to be OT. Additionally, females aged 18–19 years or with a prior
history of STIs were more likely to be OT. Females (83.6%) were more likely to be UT, while STI exposure,
genito-urinary symptoms, and a prior history of STI were protective of UT .
Conclusion: Adolescents and young adults screened for STIs have a high prevalence of GC/CT. A
signiﬁcant proportion of these patients end up over-treated and an even higher proportion are under-
treated.
 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Adolescents and young adults have a disproportionately higher
burden of sexually transmitted infections (STIs) compared to other
age groups: 15–24-year-olds have the highest rates of both
Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC).1 In
2014, this age group accounted for 65% of CT infections and 53% of
GC infections in the USA .1 Furthermore, the county in which the
present study was conducted, Cook County, Illinois, is ranked
second in the USA for the highest rates of both CT and GC infections
after Los Angeles County.2* Corresponding author. Tel.: +1 773 870 5203; fax: +1 312 996 9693.
E-mail address: mjanaene@gmail.com (M. Anaene).
http://dx.doi.org/10.1016/j.ijid.2016.10.009
1201-9712/ 2016 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).The Centers for Disease Control and Prevention (CDC) currently
recommend annual chlamydia and gonorrhea screening for all
sexually active women under the age of 25 years, annual
chlamydia screening for young men in high prevalence clinical
settings, and annual gonorrhea screening for men who have sex
with men.3 The emergency department (ED) has long been
postulated as a potential avenue for sexually transmitted disease
screening. The ED often serves as the point of care site for difﬁcult
to reach populations, which include adolescents.4 Adolescents are
known to under-utilize primary care services and over-depend on
the ED for routine health care, especially when they lack health
insurance.5–7
Screening for STIs may be accompanied by treatment, but often
patients screened for STIs may end up being over-treated or under-
treated. When compared to physician ofﬁce visits, one study found
that EDs diagnosed CT in 70% more visits and were more likely tociety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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treatment.8 It appears that the research performed to date has
focused on under-treatment (UT) of CT/GC; over-treatment (OT) is
rarely reported.9 In addition, most studies have focused on
adolescent and adult females but not males.9 Jenkins et al.
reported that UT rates ranged from 43% to 84%, with slightly lower
rates in female-only studies and even lower rates for symptomatic
males, while OT rates ranged from 6.7% to 31.9% with higher rates
in symptomatic males.9
The purpose of this study was to measure the prevalence
of CT/GC in an ED in a large public hospital, the rates of OT
and UT, and factors associated with OT and UT for both female
and male adolescent and young adult patients in a high-risk
region.
2. Methods
2.1. Study design
A retrospective chart review of adolescents and young adults
who presented to the Pediatric Emergency Department of John H.
Stroger Hospital of Cook County and who were screened for GC/CT
during a 12-month period (July 2014 to June 2015) was conducted.
The hospital institutional review board approved the study
protocol and data collection tool.
2.2. Study setting and population
John H. Stroger Hospital of Cook County is an urban public
safety net hospital that provides care to all patients regardless of
their ability to pay. The pediatric emergency department treats
over 45 000 children, adolescents, and young adults annually,
caring for patients until 24 years of age. Due to the high
prevalence of STIs in this patient population, adolescents and
young adults presenting to this ED are screened irrespective of
the presenting complaint, but have the option to ‘opt out’ of the
screening.
Adolescent and young adult patients aged 13–24 years who
presented to the ED during the study period and who were
screened for GC/CT were eligible to be included. Exclusion factors
included adolescents who presented for a sexual assault examina-
tion or who had missing GC/CT test results.
2.3. Data collection
The practice of the pediatric ED is to keep a log of all patients
screened for any STI to facilitate follow-up of the laboratory
results. These logs were matched with patient medical records,
and the medical records were reviewed for up to 6 months after
the last ED visit to document follow-up and/or treatment. Study
data were primarily collected using REDCap electronic data
capture tools.10
A chart abstraction form was developed to record baseline
demographics, patient history, clinical management, laboratory
results, and follow-up. Baseline demographics included age, sex,
ethnicity, race, and insurance status. Based on the frequency
distribution, age was re-coded from a continuous variable to a
three-level categorical variable. Patient history included docu-
mented presenting symptoms, recent STI exposure, and past
history of STIs. Presenting symptoms were coded as either genito-
urinary (GU) or non-GU. GU symptoms included urinary symp-
toms, vaginal discharge, abnormal vaginal bleeding, and penile
discharge. All other symptoms were classiﬁed as non-GU
symptoms. Management included treatment given during the
ED visit and the discharge diagnosis. Laboratory data provided
results for nucleic acid ampliﬁcation testing (NAAT) of chlamydiaor gonorrhea. Adequate treatment was based on the prescription of
medication according to the standard CDC guidelines during the
initial ED encounter.3 Over-treatment was deﬁned as a patient who
was treated empirically for GC/CT during the initial visit but had
negative laboratory results. Under-treatment was deﬁned as a
patient who had a positive laboratory result for either GC or CT but
was not initially treated. Follow-up was considered successful if it
was documented in the medical records that the provider had
informed the patient of their result and prescribed the appropriate
therapy.
2.4. Outcome measures
The primary outcomes of the study were the rates of Neisseria
gonorrhoeae (GC), Chlamydia trachomatis (CT), and co-infection
with GC/CT, the rate and factors associated with OT, and the rate
and factors associated with UT.
2.5. Statistical analysis
All analyses were performed using IBM SPSS Statistics version
23.0 software (IBM Corp., Armonk, NY, USA).11 Data were initially
collected for up to ﬁve ED visits to capture repeat presenters. For
this study, the initial ED visit was taken into consideration and any
subsequent visits were not analyzed. Data from subsequent visits
are currently being analyzed for re-infection rates as part of
another article.
Descriptive statistics were used to describe the demographic
variables and clinical factors. To measure OT and UT, the dataset
was divided into two groups, the GC/CT-positive group and the GC/
CT-negative group. Comparisons of the two groups were explored
using the Chi-square test of independence.
Sub-analyses of the GC/CT-negative and GC/CT-positive groups
were conducted to determine factors that predicted OT or UT,
respectively. Factors that were moderately associated with the
treatment outcome using bivariate analysis (p  0.1), as well as
moderately signiﬁcant interaction terms between demographic
and clinical factor variables (p  0.2), were entered into the
multivariate log binomial regression analysis. Using manual
backward conditional deletion, main effects (p > 0.05) and
interaction terms (p > 0.10) were removed sequentially. The main
effects that were not signiﬁcant were removed and left out if found
not to have a confounding effect (change in risk ratio (RR)
by > 10%). The Hosmer–Lemeshow test was used to assess the
goodness of ﬁt of the regression models.
3. Results
During the study period, 797 adolescents and young adults
were screened for GC/CT during their initial visit and were
recruited following the application of the inclusion and exclusion
criteria. The subjects ranged in age from 13 to 24 years (mean age
18.9, standard deviation 1.44 years). The majority of the study
population was black (59.7%) and female (66.1%) (Table 1). More
than half of the subjects were insured (54.8%; Medicaid n = 408,
private insurance, n = 29); 45.2% were uninsured (n = 360). Most of
the subjects did not report known exposure to STIs (91.1%), had no
prior history of STIs (81.3%), and had non-GU presenting symptoms
(34.3%).
Demographic and clinical factor variables among those who
tested positive versus those who tested negative for GC/CT are
shown in Table 1. Race was the only demographic variable that was
signiﬁcantly different between the two groups. For clinical factors,
the GC/CT-positive group was more likely to report recent STI
exposure, have a prior history of STIs, and present with GU
symptoms (p < 0.01).
Table 1
Study characteristics.
STI-negative
(n = 626) (%)
STI-positive
(n = 171)(%)
p-Value
Demographics
Age, years 13–17 92 (14.7) 30 (17.5) 0.65
18–19 268 (42.8) 72 (42.1)
20 266 (42.5) 69 (40.4)
Race Black 353 (56.4) 123 (71.9) <0.01
Non-black 273 (43.6) 48 (28.1)
Sex Female 410 (65.5) 117 (68.4) 0.47
Male 216 (34.5) 54 (31.6)
Insurance Private/Medicaid 349 (55.8) 88 (51.5) 0.32
Uninsured 277 (44.2) 83 (48.5)
Clinical factors
STI exposure Yes 41 (6.5) 30 (17.5) <0.01
No 585 (93.5) 141 (82.5)
History of STI Yes 103 (16.5) 46 (26.9) <0.01
No 523 (83.5) 125 (73.1)
Presenting
symptoms
GU 192 (30.7) 81 (47.4) <0.01
Non-GU 434 (69.3) 90 (52.6)
STI, sexually transmitted infection; GU, genito-urinary.
Table 2
Sexually transmitted disease diagnosis and ED treatment
Not treated in ED
n (%)
Treated in ED
n (%)
Total
n (%)
Negative GC/CT 490 (78.3) 136 (21.6) 626 (100)
Positive GC/CT 74 (43.4) 97 (56.7) 171 (100)
ED, Emergency Department; GC, Neisseria gonorrhoeae; CT, Chlamydia trachoma-
tis.
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Overall, 171 (21.6%) patients tested positive for an STI (GC, CT,
or both): 152 (19.1%) patients were positive for CT, 44 (5.5%) for GC,
and 25 (3.1%) were co-infected with GC/CT (Fig. 1). One hundred
and thirty-six (21.6%) subjects were over-treated and 74 (43.4%)
subjects were under-treated (Table 2).
3.2. Factors associated with over-treatment and under-treatment
3.2.1. Over-treatment (OT)
Fig. 2 shows the results of the bivariate analysis. Multivariable
logistic regression was performed to ascertain the effects of age,
sex, STI exposure, STI history, and presenting complaint on the
likelihood that subjects were OT (Table 3). A signiﬁcant interaction
between sex and the presenting complaint was found, thus results
were stratiﬁed by sex.
Female patients with OT were more likely to be aged 18–19
years (RR 2.13, 95% conﬁdence interval (CI) 1.18–3.84), present
with STI exposure (RR 97.83, 95% CI 12.50–763.4), have a prior
history of STIs (RR 3.78, 95% CI 2.07–6.88), and present with GU
symptoms (RR 2.34, 95% CI 1.36–4.02). The goodness of ﬁt test was
0.89 for the female OT regression model.
Male patients with OT were more likely to present with STI
exposure (RR 31.76, 95% CI 7.35–137.22) and have GU presenting
symptoms (RR 8.07, 95% CI 3.26–19.95). Age and a prior history of
STI were not statistically signiﬁcant. The goodness of ﬁt test was
0.80 for the male OT regression model.Fig. 1. Rates of chlamydia and gonorrhea infection in the study patients (n = 797).3.2.2. Under-treatment (UT)
Fig. 3 shows the results of the bivariate analysis. Multivariable
logistic regression was performed to ascertain the effects of sex, STI
exposure, STI history, and presenting complaint on the likelihood
that subjects were UT (Table 4).
All predictor variables were statistically signiﬁcant. A subject
was more likely to be UT if they were female (RR 3.28, 95% CI 1.34–
8.05) and was less likely to be UT if they presented with STI
exposure (RR 0.03, 95% CI 0.003–0.21), had a prior history of STIs
(RR 0.13, 95% CI 0.05–0.33), and had GU symptoms (RR 0.26, 95% CI
0.12–0.57) (Table 4). The goodness of ﬁt test was 0.34 for the UT
regression model.
Of the 74 individuals who were not initially treated, 49 (66.2%)
were contacted and informed of their diagnosis. Of these, 33
(44.6%) sought treatment in the ED.
4. Discussion
This study demonstrated a considerable burden of infection
with CT and GT among adolescents and young adult patients
presenting to a pediatric ED in inner city Chicago. The overall
prevalence of GC and CT was 21.6%. CT was the most prevalent STI.
These rates are similar to those reported in two studies, but are
substantially higher than other rates reported in the litera-
ture.4,12–19 This study also revealed a disproportionate prevalence
of STI infection in black subjects, which is similar to the racial
disparities reported by the CDC.20
The presence or lack of insurance was the only factor that was
not associated with OT or UT. This is to be expected, as many
patients were uninsured and this is a safety net hospital that cares
for individuals regardless of their ability to pay.
The OT rate was comparable to the rates found in other studies.9
Given the high prevalence of STIs in the present study population,
it is not striking that patients are over-treated. For females, being
aged 18–19 years, STI exposure, history of STI, and GU symptoms
predicted OT, while for males, STI exposure and GU symptoms
predicted OT.
Currently, guidelines for the empiric treatment of STIs are vague
and thus the use of empiric treatment is left to the physician’sFig. 2. Unadjusted risk ratio (RR) for factors associated with over-treatment.
Table 3
Adjusted risk ratio for factors associated with over-treatment stratiﬁed by sex.
Female Male
RR (95% CI) p-Value RR (95% CI) p-Value
Age, years 13–17 1.23 (0.49, 3.04) 0.66 1.84 (0.54, 3.94) 0.33
18–19 2.13 (1.18, 3.84) 0.01 1.46 (0.54, 3.94) 0.45
20 Ref. Ref.
STI exposure Yes 97.83 (12.5, 763.4) <0.001 31.76 (7.35, 137.22) <0.01
No Ref. Ref.
History of STI Yes 3.78 (2.07, 6.88) <0.001 0.92 (0.25, 3.37) 0.90
No Ref. Ref.
Presenting complaint GU 2.34 (1.36, 4.02) 0.002 8.07 (3.26, 19.95) <0.01
Non-GU Ref. Ref.
RR, risk ratio; CI, conﬁdence interval; STI, sexually transmitted infection; GU, genito-urinary.
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prolonged time interval between specimen submission and the
availability of results, as well as poor follow-up, may prompt
providers to presumptively treat adolescents presenting with STI
exposure and GU symptoms. However, OT of an adolescent can
create unnecessary emotional trauma secondary to being labeled
as having an STI and can potentially harm a monogamous
relationship.15 OT is also associated with the risk of antibiotic
resistance, especially for GC. Historically, GC has demonstrated the
ability to develop resistance to multiple drugs: sulfonamides,
penicillin, tetracycline, ﬂuroquinolones.21 Thus, OT leads to
overuse, which could potentially lead to the emergence and
spread of cephalosporin resistance.21
In comparison to other studies, the UT rate in the present study
was lower.9 Adolescents presenting with STI exposure and GU
symptoms were more likely to be appropriately treated. However,
adolescent females were more likely to be UT than males. One
reason for this may be that females are more likely to have an
indolent infection, whereas males present with more consistent
symptoms.1,3,22 Other factors can also complicate the diagnosis
and empiric treatment of STIs in females, such as pregnancy,
concurrent urinary infection, vaginal bleeding, and vulvovagini-
tis.14 Untreated CT/GC infection in women can result in several
adverse sequelae, the most serious of which include pelvic
inﬂammatory disease, ectopic pregnancy, and infertility.1,3 Fur-
thermore, UT is a public health concern, as delayed treatment
results in a potential pool of untreated adolescents and young
adults in the community who are at risk of spreading the infection.
Of the 74 patients who were not treated empirically but were
disease-positive, 49 were successfully contacted and less than half
returned for treatment. The reasons for the lack of follow-up were
unsuccessful contact attempts (e.g., phone number out of service),
no documented contact attempt in the medical charts, orFig. 3. Unadjusted risk ratio (RR) for factors associated with under-treatment.successful contact with a patient who subsequently did not return
for treatment. It is also possible that some of these subjects
received healthcare and treatment elsewhere.
The availability of a point-of-care testing for CT and GC would
substantially decrease both OT and UT, the complications
associated with them, and the number of adolescents who require
follow-up treatment. To ensure follow-up and prompt treatment of
STI-positive youths who are not presumptively treated, modern
methods of communication should be employed. To address the
lack of follow-up, perhaps other avenues of screening and treatment
could be employed, such as school-based health centers and
primary care ambulatory care settings. One of the reasons that
adolescents and young adults under-utilize ambulatory services is
the lack of adequate health insurance.6,7 The Affordable Healthcare
Act (ACA) may enable more adolescents to obtain their care from
primary care sites where they can have continuity of care. Further,
other modern methods of communication could be utilized to
improve communication and follow-up, such as e-mail or patient
portal notiﬁcation. Phone notiﬁcation at the study institution can be
unreliable, as the patients tend to change phone numbers
frequently, whereas e-mail addresses remain more consistent over
time. EDs can also partner up with local health departments (LHDs)
who frequently manage STI-positive individuals and can be a source
of co-managing and tracking down patients lost to follow-up.9
This study has some limitations. The study was conducted at a
single, urban, public hospital that caters for the underserved and
uninsured patients residing in a county with a high prevalence of
STIs. Thus, the management patterns and results may not be
generalizable to other adolescent and young adult populations that
have a low prevalence of STIs.
A retrospective review of the medical charts was conducted and
variable documentation by different providers and incomplete
medical records were encountered. Hence this study may have
been prone to misclassiﬁcation and selection biases and may
have been subject to confounding, as some risk factors may have
been present but not recorded.Table 4
Adjusted risk ratio for factors associated with under-treatment.
RR (95% CI) p-Value
Sex Female 3.28 (1.34, 8.05) 0.01
Male Ref.
STI exposure Yes 0.03 (0.003, 0.21) 0.001
No Ref.
History of STI Yes 0.13 (0.05, 0.33) <0.01
No Ref.
Presenting complaint GU 0.26 (0.12, 0.57) <0.01
Non-GU Ref.
RR, risk ratio; CI, conﬁdence interval; STI, sexually transmitted infection; GU,
genito-urinary.
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cannot be accounted for with regard to the subjects who did not
follow-up for treatment. Therefore the actual treatment follow-up
rate may be higher than reported.
In conclusion, this study showed that a signiﬁcant proportion of
adolescents end up over-treated and an even higher proportion are
under-treated. Providers are faced with the difﬁcult decision to
empirically treat or not treat an adolescent presenting with
possible sexually transmitted disease exposure and/or GU
symptoms. Females who are more likely to suffer from the
sequelae of STIs are more likely to be UT. Further investigation into
the institution of modern methods of patient communication
aimed at increasing follow-up is warranted. Efforts should also be
made to enroll adolescents and young adults in health insurance
plans that will enable them to seek care at primary care sites for
continuity of care.
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